Alternative Treatment Paradigm for Natalizumab Trial
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
At a glance
- Drugs Glatiramer acetate (Primary) ; Methylprednisolone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ATP
- 02 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
- 26 Apr 2013 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 26 Apr 2013 Planned initiation date (Jul 2013) added as reported by ClinicalTrials.gov.